Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment–Elevation Myocardial Infarction: A Propensity Score–Matched Analysis
暂无分享,去创建一个
M. Jeong | Y. Ahn | Young Jo Kim | M. Cho | C. Kim | D. Sim | S. Chae | T. Hong | I. Seong | J. Chae | K. Seung | Seung‐Jung Park | J. Bae | S. Rha
[1] E. Antman,et al. Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data Registry. , 2015, JAMA internal medicine.
[2] M. Jeong,et al. The scientific achievements of the decades in Korean Acute Myocardial Infarction Registry , 2014, The Korean journal of internal medicine.
[3] P. Armstrong,et al. ST–Segment-Elevation Myocardial Infarction Patients Randomized to a Pharmaco-Invasive Strategy or Primary Percutaneous Coronary Intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-Year Mortality Follow-Up , 2014, Circulation.
[4] N. Danchin,et al. Weaknesses in regional primary coronary angioplasty programs: is there still a role for a pharmaco-invasive approach? , 2014, Revista espanola de cardiologia.
[5] Nicolas Danchin,et al. Limitaciones de los programas regionales de angioplastia coronaria primaria: ¿la estrategia farmacoinvasiva todavía es una alternativa? , 2014 .
[6] J. Ferrières,et al. Five-Year Survival in Patients With ST-Segment–Elevation Myocardial Infarction According to Modalities of Reperfusion Therapy: The French Registry on Acute ST-Elevation and Non–ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort , 2014, Circulation.
[7] P. Armstrong,et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.
[8] Jane A. Linderbaum,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[9] D. Atar,et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. , 2012, European heart journal.
[10] T. Henry,et al. Benefit of Transferring ST-Segment–Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays Increase , 2011, Circulation.
[11] U. Khot,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Circulation.
[12] G. Levine,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Journal of the American College of Cardiology.
[13] Marco Valgimigli,et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.
[14] B. Brodie. Facilitated percutaneous coronary intervention still searching for the right patients. , 2011, JACC. Cardiovascular interventions.
[15] P. Armstrong,et al. The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study. , 2010, American heart journal.
[16] J. Ferrières,et al. Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Acute Myocardial Infarction: Data From the French Registry on Acute ST-Elevation Myocardial Infarction (FAST-MI) , 2008, Circulation.
[17] David P Miller,et al. Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy , 2006, Circulation.
[18] P. Armstrong,et al. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial , 2006, The Lancet.
[19] B. Nallamothu,et al. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? , 2003, The American journal of cardiology.
[20] J. Boura,et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials , 2003, The Lancet.
[21] D. Rubin,et al. Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score , 1985 .
[22] K. Mahaffey,et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation , 2012 .
[23] B. Gersh. Facilitated PCI in Patients with ST-Elevation Myocardial Infarction , 2009 .
[24] Jacob Cohen. The t Test for Means , 1977 .